Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.38 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | CTSD | P07339 | 1/20 | 0.37 |
| ▸ | CTSE | P14091 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5367479 | 0.88 | F2 (0.42) | RENOPRD1NTSR1F2 | |
| SCHEMBL29800924 | 0.87 | FAP (0.39) | RENFAP | |
| SCHEMBL5367473 | 0.84 | PTPN1 (0.41) | RENOPRD1NTSR1F2 | |
| SCHEMBL29399877 | 0.84 | NTSR1 (0.46) | OPRD1NTSR1F2 | |
| SCHEMBL31067238 | 0.80 | NTSR1 (0.50) | OPRD1NTSR1F2 | |
| SCHEMBL29569246 | 0.80 | NTSR1 (0.44) | OPRD1NTSR1F2CTSDCTSE | |
| SCHEMBL29800934 | 0.79 | PTPN1 (0.42) | OPRD1NTSR1CXCR4CTSDCTSE | |
| SCHEMBL29814554 | 0.79 | PTPN1 (0.43) | RENNTSR1CXCR4F2 | |
| SCHEMBL31748807 | 0.78 | NTSR1 (0.43) | RENOPRD1NTSR1 | |
| SCHEMBL5367237 | 0.78 | CXCR4 (0.48) | CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109420179-B | Docetaxel targeted prodrug and anti-colon cancer medicinal application thereof | 复旦大学 | 2022-08-26 | — | — | CN | disclosed |